Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-14 Sale | 2025-11-14 8:00 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 2,000 | $65 | $130,000 | 197,871 (Direct) | View |
| 2025-11-11 Sale | 2025-11-13 8:37 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 1,000 | $60 | $60,000 | 199,871 (Direct) | View |
| 2025-11-13 Sale | 2025-11-13 8:24 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 20,000 | $63.01 | $1,260,236 | 1,272,987 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 10,785 | $55.07 | $593,903 | 435,573 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 5,110 | $39.8 | $203,378 | 446,358 (Direct) | View |
| 2025-09-03 Sale | 2025-09-05 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,725 | $37.87 | $103,198 | 233,548 (Direct) | View |
| 2025-08-06 Sale | 2025-08-08 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,725 | $37.78 | $102,951 | 236,273 (Direct) | View |
| 2025-07-02 Sale | 2025-07-03 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 10,090 | $45.09 | $454,954 | 403,008 (Direct) | View |
| 2025-06-04 Sale | 2025-06-06 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,725 | $36.96 | $100,716 | 241,723 (Direct) | View |
| 2025-05-07 Sale | 2025-05-09 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,725 | $35.75 | $97,419 | 244,448 (Direct) | View |
| 2025-04-02 Sale | 2025-04-04 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 3,860 | $36.22 | $139,801 | 247,173 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,590 | $30.48 | $48,463 | 251,033 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 10,000 | $30.15 | $301,511 | 1,292,987 (Direct) | View |
| 2025-02-05 Sale | 2025-02-07 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 3,520 | $40.69 | $143,229 | 423,998 (Direct) | View |
| 2025-02-05 Sale | 2025-02-07 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $40.58 | $608,700 | 1,302,987 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 8:00 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $48.85 | $732,693 | 1,309,487 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 4,085 | $46.94 | $191,740 | 427,518 (Direct) | View |
| 2024-12-12 Purchase | 2024-12-16 06:00 am | Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director | 20,000 | $49.54 | $990,775 | 20,000 (Direct) | View |
| 2024-12-11 Sale | 2024-12-13 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 4,540 | $48.76 | $221,363 | 431,603 (Direct) | View |
| 2024-12-04 Sale | 2024-12-06 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 6,665 | $46.07 | $307,057 | 260,798 (Direct) | View |
| 2024-12-04 Sale | 2024-12-06 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $46.58 | $698,654 | 1,324,487 (Direct) | View |
| 2024-11-06 Sale | 2024-11-08 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 6,665 | $59.12 | $394,041 | 267,463 (Direct) | View |
| 2024-11-06 Sale | 2024-11-08 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $59.22 | $888,320 | 1,339,487 (Direct) | View |
| 2024-10-02 Sale | 2024-10-04 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 6,665 | $56.26 | $374,954 | 274,128 (Direct) | View |
| 2024-10-02 Sale | 2024-10-04 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $56.23 | $2,249,307 | 1,354,487 (Direct) | View |
| 2024-09-04 Sale | 2024-09-06 8:03 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 6,665 | $47.56 | $316,969 | 280,793 (Direct) | View |
| 2024-09-04 Sale | 2024-09-06 8:02 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $47.62 | $1,904,841 | 1,394,487 (Direct) | View |
| 2024-08-23 Sale | 2024-08-23 8:05 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 6,000 | $48.26 | $289,560 | 200,871 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-05 Exercise | 2025-11-07 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 8,060 | $22.86 | 435,573 (Direct) | View |
| 2025-11-05 Exercise | 2025-11-07 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 8,060 | $0 | 435,573 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,385 | $22.86 | 446,358 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,385 | $0 | 446,358 (Direct) | View |
| 2025-07-02 Exercise | 2025-07-03 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 7,365 | $22.86 | 403,008 (Direct) | View |
| 2025-07-02 Exercise | 2025-07-03 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 7,365 | $0 | 403,008 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:06 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 28,922 | $0 | 28,922 (Indirect) | View |
| 2025-06-17 Option Award | 2025-06-20 8:05 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Shah Nimish P Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:04 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:03 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:02 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Gottesdiener Andrew Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:01 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Fox Jennifer A. Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:00 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Bollinger Lisa Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 8:02 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 795 | $22.86 | 423,998 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 8:02 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 795 | $0 | 423,998 (Direct) | View |
| 2025-01-31 Exercise | 2025-01-31 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 8,500 | $22.86 | 1,707,999 (Direct) | View |
| 2025-01-31 Exercise | 2025-01-31 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 8,500 | $0 | 1,707,999 (Direct) | View |
| 2025-01-02 Exercise | 2025-01-03 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,360 | $22.86 | 427,518 (Direct) | View |
| 2025-01-02 Exercise | 2025-01-03 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,360 | $0 | 427,518 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 8:01 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,815 | $22.86 | 431,603 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 8:01 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,815 | $0 | 431,603 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 8:02 pm | N/A 2034-12-09 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 357,036 | $0 | 357,036 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 8:02 pm | N/A 2034-12-09 | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 124,962 | $0 | 124,962 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 8:01 pm | N/A 2034-12-09 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 124,962 | $0 | 124,962 (Direct) | View |